Immune Pharmaceuticals Enters a Research Partnership to Develop Mono and Bispecific Antibodies

Immune Pharmaceuticals Inc , a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of immuno-inflammatory diseases and cancers.

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company

PharmAthene, Inc and Altimmune Inc , a privately-held immunotherapeutics company targeting infectious diseases, announced the signing of a definitive agreement for the merger of PharmAthene and Altimmune in an all-stock transaction.

Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma

Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei Corporation, Tokyo, Japan.

Global pharma players trust in Swisslog to strengthen intralogistics

Swisslog, a leading automation expert for robot-based and data driven intralogistic solutions, has completed the latest expansion of the high-bay warehouse for healthcare manufacturers.

New UK primary care clinical trials company Interface Clinical Research to offer a more effective model

New clinical trials company, Interface Clinical Research, outlined a new model for running primary care clinical trials at their launch yesterday at the Royal Society in London.

Gilead Sciences Announces EMA Validation of Marketing Authorization for Investigational Chronic

Gilead Sciences, Inc announced that the company’s Marketing Authorization Application for the investigational, once-daily, single tablet regimen of sofosbuvir 400 mg.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com